These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14064462)

  • 21. [Evaluation of the absorption of salicylic acid in keratolytic therapy].
    Montagnani A; Ghetti P; Passarini B; Varotti C; Boni P; Lamedica R
    G Ital Dermatol Venereol; 1986; 121(4):293-6. PubMed ID: 3759143
    [No Abstract]   [Full Text] [Related]  

  • 22. Psoriasis of the scalp. Diagnosis and management.
    van de Kerkhof PC; Franssen ME
    Am J Clin Dermatol; 2001; 2(3):159-65. PubMed ID: 11705093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis: clinical results with a new tarallantoin cream.
    SINGER M
    Med Times; 1962 May; 90():490-2. PubMed ID: 13913298
    [No Abstract]   [Full Text] [Related]  

  • 24. Allantoin in the treatment of psoriasis: A double blind study.
    HERDENSTAM CG
    Acta Derm Venereol; 1959; 39():216-24. PubMed ID: 14401235
    [No Abstract]   [Full Text] [Related]  

  • 25. [Local effect of the nonsteroidal anti-inflammatory drug indomethacin on psoriasis].
    Knopf B; Barta U
    Dermatol Monatsschr; 1987; 173(8):454-7. PubMed ID: 3666259
    [No Abstract]   [Full Text] [Related]  

  • 26. Psoriasis--treatment with tar and allantoin cream.
    MEISTER B
    Skin (Los Angeles); 1962 Mar; 1():55-6. PubMed ID: 14472272
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid.
    Scarpa C
    Acta Derm Venereol Suppl (Stockh); 1994; 186():47. PubMed ID: 8073835
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical efficacy of flumetasone/salicylic acid ointment combined with 308-nm excimer laser for treatment of psoriasis vulgaris.
    Dong J; He Y; Zhang X; Wang Y; Tian Y; Wang J
    Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):133-6. PubMed ID: 22548394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use.
    Carroll CL; Feldman SR; Camacho FT; Manuel JC; Balkrishnan R
    J Am Acad Dermatol; 2004 Aug; 51(2):212-6. PubMed ID: 15280839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photocarcinogenesis study of glycolic acid and salicylic acid (CAS Nos. 79-14-1 and 69-72-7) in SKH-1 mice (simulated solar light and topical application study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2007 Sep; (524):1-242. PubMed ID: 21921960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.
    Baran A; Świderska M; Bacharewicz-Szczerbicka J; Myśliwiec H; Flisiak I
    Lipids; 2017 Jan; 52(1):51-60. PubMed ID: 27864793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new Cologne therapy scheme--addition of tar to cignoline-salicylic acid-white vaseline therapy in psoriasis vulgaris].
    Steigleder GK; Schulze HJ
    Z Hautkr; 1984 Feb; 59(3):188, 191-2. PubMed ID: 6719977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refractory hypoglycemia: a complication of topical salicylate therapy.
    Maurer TA; Winter ME; Koo J; Berger TG
    Arch Dermatol; 1994 Nov; 130(11):1455-7. PubMed ID: 7979460
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the therapy of psoriasis; experiences with psoriasal].
    SCHUBERT E
    Z Haut Geschlechtskr; 1954 May; 16(9):275-7. PubMed ID: 13179694
    [No Abstract]   [Full Text] [Related]  

  • 35. Adherence to topical therapy increases around the time of office visits.
    Feldman SR; Camacho FT; Krejci-Manwaring J; Carroll CL; Balkrishnan R
    J Am Acad Dermatol; 2007 Jul; 57(1):81-3. PubMed ID: 17498841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emollients, moisturizers, and keratolytic agents in psoriasis.
    Fluhr JW; Cavallotti C; Berardesca E
    Clin Dermatol; 2008; 26(4):380-6. PubMed ID: 18691519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refractory hypoglycemia secondary to topical salicylate intoxication.
    Raschke R; Arnold-Capell PA; Richeson R; Curry SC
    Arch Intern Med; 1991 Mar; 151(3):591-3. PubMed ID: 2001141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PSORIASIS; A STATISTICAL STUDY OF THE GOECKERMAN AND THE CHRYSAROBIN THERAPIES, AND OF VARIOUS FACTORS INFLUENCING THE CLINIC.
    ROSSI-SOFFAR G
    Dermatologica; 1965; 130():53-79. PubMed ID: 14276648
    [No Abstract]   [Full Text] [Related]  

  • 39. An open label prospective randomized trial to compare the efficacy of coal tar-salicylic Acid ointment versus calcipotriol/betamethasone dipropionate ointment in the treatment of limited chronic plaque psoriasis.
    Khandpur S; Sahni K
    Indian J Dermatol; 2014 Nov; 59(6):579-83. PubMed ID: 25484388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
    van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.